13 January 2017 – Global Vaccine Safety meeting: Safety of typhoid vaccines (from meeting 30 November-1 December 2016)

Overview

GACVS was presented with data on the safety of 3 generations of typhoid vaccines, including the live oral Ty21a vaccine, parenteral Vi polysaccharide, and conjugated Vi polysaccharide vaccines. The Ty21a and Vi polysaccharide vaccines are currently recommended by WHO for programmatic use to control endemic and epidemic disease,6 while a review by SAGE for recommendations on the conjugate vaccines is scheduled for 2017.